Integrated Quantitative Investments LLC Pacira Bio Sciences, Inc. Transaction History
Integrated Quantitative Investments LLC
- $340 Billion
- Q2 2025
A detailed history of Integrated Quantitative Investments LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Integrated Quantitative Investments LLC holds 10,379 shares of PCRX stock, worth $231,036. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,379
Previous 39,000
73.39%
Holding current value
$231,036
Previous $969 Million
74.4%
% of portfolio
0.07%
Previous 0.48%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
258Shares Held
51.2MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$178 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$120 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$53.3 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$50.2 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$47.9 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.02B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...